{"transactions":[{"id":1731318,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":92274,"kind":"organization","name":"Vivo Capital VIII, LLC","position":1,"cik":"0001618789","reported_name":"Vivo Capital VIII, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":92275,"kind":"organization","name":"Vivo Capital Fund VIII, L.P.","position":2,"cik":"0001618788","reported_name":"Vivo Capital Fund VIII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":92276,"kind":"organization","name":"Vivo Capital Surplus Fund VIII, L.P.","position":3,"cik":"0001628048","reported_name":"Vivo Capital Surplus Fund VIII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":30106,"kind":"organization","name":"Vivo Opportunity, LLC","position":4,"cik":"0001728970","reported_name":"Vivo Opportunity, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":30107,"kind":"organization","name":"Vivo Opportunity Fund Holdings, L.P.","position":5,"cik":"0001930214","reported_name":"Vivo Opportunity Fund Holdings, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":107995,"kind":"organization","name":"Vivo Panda, LLC","position":6,"cik":"0001843847","reported_name":"Vivo Panda, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":107996,"kind":"organization","name":"Vivo Panda Fund, L.P.","position":7,"cik":"0001675490","reported_name":"Vivo Panda Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-11-22T23:51:43.000Z","date":"2023-11-21","kind":"sale","planned":false,"acquired":false,"shares":1457,"price":0.9,"value":1311.3,"ownership":{"direct":false,"nature":"By: Vivo Opportunity Fund Holdings, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported herein is a weighted average price. These shares were sold on the open market in multiple transactions at prices ranging from $0.90 to $0.90, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the ranges set forth in footnote (4) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are held of record by Vivo Opportunity Fund Holdings, L.P. Vivo Opportunity, LLC is the General Partner of Vivo Opportunity Holdings, L.P. Vivo Opportunity, LLC disclaims beneficial ownership over such securities except to the extent of its pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes."}],"balance_after":111662,"source":{"system":"sec-edgar","filing":"0001213900-23-089692","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1728970/000121390023089692/ownership.xml","form_type":"4"}},{"id":1731317,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":92274,"kind":"organization","name":"Vivo Capital VIII, LLC","position":1,"cik":"0001618789","reported_name":"Vivo Capital VIII, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":92275,"kind":"organization","name":"Vivo Capital Fund VIII, L.P.","position":2,"cik":"0001618788","reported_name":"Vivo Capital Fund VIII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":92276,"kind":"organization","name":"Vivo Capital Surplus Fund VIII, L.P.","position":3,"cik":"0001628048","reported_name":"Vivo Capital Surplus Fund VIII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":30106,"kind":"organization","name":"Vivo Opportunity, LLC","position":4,"cik":"0001728970","reported_name":"Vivo Opportunity, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":30107,"kind":"organization","name":"Vivo Opportunity Fund Holdings, L.P.","position":5,"cik":"0001930214","reported_name":"Vivo Opportunity Fund Holdings, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":107995,"kind":"organization","name":"Vivo Panda, LLC","position":6,"cik":"0001843847","reported_name":"Vivo Panda, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":107996,"kind":"organization","name":"Vivo Panda Fund, L.P.","position":7,"cik":"0001675490","reported_name":"Vivo Panda Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-11-22T23:51:43.000Z","date":"2023-11-21","kind":"sale","planned":false,"acquired":false,"shares":236,"price":0.9,"value":212.4,"ownership":{"direct":false,"nature":"By: Vivo Capital Surplus Fund VIII, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported herein is a weighted average price. These shares were sold on the open market in multiple transactions at prices ranging from $0.90 to $0.90, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the ranges set forth in footnote (4) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held of record by Vivo Capital Surplus Fund VIII, L.P. Capital VIII, LLC is the General Partner of Vivo Capital Surplus Fund VIII, L.P. Vivo Capital VIII, LLC disclaims beneficial ownership over such securities except to the extent of its pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes."}],"balance_after":269587,"source":{"system":"sec-edgar","filing":"0001213900-23-089692","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1728970/000121390023089692/ownership.xml","form_type":"4"}},{"id":1731316,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":92274,"kind":"organization","name":"Vivo Capital VIII, LLC","position":1,"cik":"0001618789","reported_name":"Vivo Capital VIII, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":92275,"kind":"organization","name":"Vivo Capital Fund VIII, L.P.","position":2,"cik":"0001618788","reported_name":"Vivo Capital Fund VIII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":92276,"kind":"organization","name":"Vivo Capital Surplus Fund VIII, L.P.","position":3,"cik":"0001628048","reported_name":"Vivo Capital Surplus Fund VIII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":30106,"kind":"organization","name":"Vivo Opportunity, LLC","position":4,"cik":"0001728970","reported_name":"Vivo Opportunity, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":30107,"kind":"organization","name":"Vivo Opportunity Fund Holdings, L.P.","position":5,"cik":"0001930214","reported_name":"Vivo Opportunity Fund Holdings, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":107995,"kind":"organization","name":"Vivo Panda, LLC","position":6,"cik":"0001843847","reported_name":"Vivo Panda, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":107996,"kind":"organization","name":"Vivo Panda Fund, L.P.","position":7,"cik":"0001675490","reported_name":"Vivo Panda Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-11-22T23:51:43.000Z","date":"2023-11-21","kind":"sale","planned":false,"acquired":false,"shares":1707,"price":0.9,"value":1536.3,"ownership":{"direct":false,"nature":"By: Vivo Capital Fund VIII, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported herein is a weighted average price. These shares were sold on the open market in multiple transactions at prices ranging from $0.90 to $0.90, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the ranges set forth in footnote (4) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The shares are held of record by Vivo Capital Fund VIII, L.P. Vivo Capital VIII, LLC is the General Partner of Vivo Capital Fund VIII, L.P. Vivo Capital VIII, LLC disclaims beneficial ownership over such securities except to the extent of its pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes."}],"balance_after":1952302,"source":{"system":"sec-edgar","filing":"0001213900-23-089692","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1728970/000121390023089692/ownership.xml","form_type":"4"}},{"id":1734699,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":92274,"kind":"organization","name":"Vivo Capital VIII, LLC","position":1,"cik":"0001618789","reported_name":"Vivo Capital VIII, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":92275,"kind":"organization","name":"Vivo Capital Fund VIII, L.P.","position":2,"cik":"0001618788","reported_name":"Vivo Capital Fund VIII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":92276,"kind":"organization","name":"Vivo Capital Surplus Fund VIII, L.P.","position":3,"cik":"0001628048","reported_name":"Vivo Capital Surplus Fund VIII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":30106,"kind":"organization","name":"Vivo Opportunity, LLC","position":4,"cik":"0001728970","reported_name":"Vivo Opportunity, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":30107,"kind":"organization","name":"Vivo Opportunity Fund Holdings, L.P.","position":5,"cik":"0001930214","reported_name":"Vivo Opportunity Fund Holdings, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":107995,"kind":"organization","name":"Vivo Panda, LLC","position":6,"cik":"0001843847","reported_name":"Vivo Panda, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":107996,"kind":"organization","name":"Vivo Panda Fund, L.P.","position":7,"cik":"0001675490","reported_name":"Vivo Panda Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-11-21T02:09:11.000Z","date":"2023-11-20","kind":"sale","planned":false,"acquired":false,"shares":23443,"price":0.92,"value":21567.56,"ownership":{"direct":false,"nature":"By: Vivo Opportunity Fund Holdings, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported herein is a weighted average price. These shares were sold on the open market in multiple transactions at prices ranging from $0.92 to $0.98, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the ranges set forth in footnote (6) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are held of record by Vivo Opportunity Fund Holdings, L.P. Vivo Opportunity, LLC is the General Partner of Vivo Opportunity Holdings, L.P. Vivo Opportunity, LLC disclaims beneficial ownership over such securities except to the extent of its pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes."}],"balance_after":113119,"source":{"system":"sec-edgar","filing":"0001213900-23-088909","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1728970/000121390023088909/ownership.xml","form_type":"4"}},{"id":1734698,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":92274,"kind":"organization","name":"Vivo Capital VIII, LLC","position":1,"cik":"0001618789","reported_name":"Vivo Capital VIII, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":92275,"kind":"organization","name":"Vivo Capital Fund VIII, L.P.","position":2,"cik":"0001618788","reported_name":"Vivo Capital Fund VIII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":92276,"kind":"organization","name":"Vivo Capital Surplus Fund VIII, L.P.","position":3,"cik":"0001628048","reported_name":"Vivo Capital Surplus Fund VIII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":30106,"kind":"organization","name":"Vivo Opportunity, LLC","position":4,"cik":"0001728970","reported_name":"Vivo Opportunity, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":30107,"kind":"organization","name":"Vivo Opportunity Fund Holdings, L.P.","position":5,"cik":"0001930214","reported_name":"Vivo Opportunity Fund Holdings, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":107995,"kind":"organization","name":"Vivo Panda, LLC","position":6,"cik":"0001843847","reported_name":"Vivo Panda, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":107996,"kind":"organization","name":"Vivo Panda Fund, L.P.","position":7,"cik":"0001675490","reported_name":"Vivo Panda Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-11-21T02:09:11.000Z","date":"2023-11-20","kind":"sale","planned":false,"acquired":false,"shares":3792,"price":0.92,"value":3488.64,"ownership":{"direct":false,"nature":"By: Vivo Capital Surplus Fund VIII, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported herein is a weighted average price. These shares were sold on the open market in multiple transactions at prices ranging from $0.92 to $0.98, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the ranges set forth in footnote (6) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held of record by Vivo Capital Surplus Fund VIII, L.P. Capital VIII, LLC is the General Partner of Vivo Capital Surplus Fund VIII, L.P. Vivo Capital VIII, LLC disclaims beneficial ownership over such securities except to the extent of its pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes."}],"balance_after":269823,"source":{"system":"sec-edgar","filing":"0001213900-23-088909","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1728970/000121390023088909/ownership.xml","form_type":"4"}},{"id":1734697,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":92274,"kind":"organization","name":"Vivo Capital VIII, LLC","position":1,"cik":"0001618789","reported_name":"Vivo Capital VIII, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":92275,"kind":"organization","name":"Vivo Capital Fund VIII, L.P.","position":2,"cik":"0001618788","reported_name":"Vivo Capital Fund VIII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":92276,"kind":"organization","name":"Vivo Capital Surplus Fund VIII, L.P.","position":3,"cik":"0001628048","reported_name":"Vivo Capital Surplus Fund VIII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":30106,"kind":"organization","name":"Vivo Opportunity, LLC","position":4,"cik":"0001728970","reported_name":"Vivo Opportunity, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":30107,"kind":"organization","name":"Vivo Opportunity Fund Holdings, L.P.","position":5,"cik":"0001930214","reported_name":"Vivo Opportunity Fund Holdings, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":107995,"kind":"organization","name":"Vivo Panda, LLC","position":6,"cik":"0001843847","reported_name":"Vivo Panda, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":107996,"kind":"organization","name":"Vivo Panda Fund, L.P.","position":7,"cik":"0001675490","reported_name":"Vivo Panda Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-11-21T02:09:11.000Z","date":"2023-11-20","kind":"sale","planned":false,"acquired":false,"shares":27465,"price":0.92,"value":25267.8,"ownership":{"direct":false,"nature":"Vivo Capital Fund VIII, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported herein is a weighted average price. These shares were sold on the open market in multiple transactions at prices ranging from $0.92 to $0.98, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the ranges set forth in footnote (6) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The shares are held of record by Vivo Capital Fund VIII, L.P. Vivo Capital VIII, LLC is the General Partner of Vivo Capital Fund VIII, L.P. Vivo Capital VIII, LLC disclaims beneficial ownership over such securities except to the extent of its pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes."}],"balance_after":1954009,"source":{"system":"sec-edgar","filing":"0001213900-23-088909","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1728970/000121390023088909/ownership.xml","form_type":"4"}},{"id":1734696,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":92274,"kind":"organization","name":"Vivo Capital VIII, LLC","position":1,"cik":"0001618789","reported_name":"Vivo Capital VIII, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":92275,"kind":"organization","name":"Vivo Capital Fund VIII, L.P.","position":2,"cik":"0001618788","reported_name":"Vivo Capital Fund VIII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":92276,"kind":"organization","name":"Vivo Capital Surplus Fund VIII, L.P.","position":3,"cik":"0001628048","reported_name":"Vivo Capital Surplus Fund VIII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":30106,"kind":"organization","name":"Vivo Opportunity, LLC","position":4,"cik":"0001728970","reported_name":"Vivo Opportunity, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":30107,"kind":"organization","name":"Vivo Opportunity Fund Holdings, L.P.","position":5,"cik":"0001930214","reported_name":"Vivo Opportunity Fund Holdings, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":107995,"kind":"organization","name":"Vivo Panda, LLC","position":6,"cik":"0001843847","reported_name":"Vivo Panda, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":107996,"kind":"organization","name":"Vivo Panda Fund, L.P.","position":7,"cik":"0001675490","reported_name":"Vivo Panda Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-11-21T02:09:11.000Z","date":"2023-11-17","kind":"sale","planned":false,"acquired":false,"shares":7009,"price":0.93,"value":6518.37,"ownership":{"direct":false,"nature":"By: Vivo Opportunity Fund Holdings, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported herein is a weighted average price. These shares were sold on the open market in multiple transactions at prices ranging from $0.93 to $0.95, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the ranges set forth in footnote (5) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are held of record by Vivo Opportunity Fund Holdings, L.P. Vivo Opportunity, LLC is the General Partner of Vivo Opportunity Holdings, L.P. Vivo Opportunity, LLC disclaims beneficial ownership over such securities except to the extent of its pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes."}],"balance_after":136562,"source":{"system":"sec-edgar","filing":"0001213900-23-088909","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1728970/000121390023088909/ownership.xml","form_type":"4"}},{"id":1734695,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":92274,"kind":"organization","name":"Vivo Capital VIII, LLC","position":1,"cik":"0001618789","reported_name":"Vivo Capital VIII, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":92275,"kind":"organization","name":"Vivo Capital Fund VIII, L.P.","position":2,"cik":"0001618788","reported_name":"Vivo Capital Fund VIII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":92276,"kind":"organization","name":"Vivo Capital Surplus Fund VIII, L.P.","position":3,"cik":"0001628048","reported_name":"Vivo Capital Surplus Fund VIII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":30106,"kind":"organization","name":"Vivo Opportunity, LLC","position":4,"cik":"0001728970","reported_name":"Vivo Opportunity, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":30107,"kind":"organization","name":"Vivo Opportunity Fund Holdings, L.P.","position":5,"cik":"0001930214","reported_name":"Vivo Opportunity Fund Holdings, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":107995,"kind":"organization","name":"Vivo Panda, LLC","position":6,"cik":"0001843847","reported_name":"Vivo Panda, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":107996,"kind":"organization","name":"Vivo Panda Fund, L.P.","position":7,"cik":"0001675490","reported_name":"Vivo Panda Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-11-21T02:09:11.000Z","date":"2023-11-17","kind":"sale","planned":false,"acquired":false,"shares":1134,"price":0.93,"value":1054.62,"ownership":{"direct":false,"nature":"By: Vivo Capital Surplus Fund VIII, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported herein is a weighted average price. These shares were sold on the open market in multiple transactions at prices ranging from $0.93 to $0.95, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the ranges set forth in footnote (5) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held of record by Vivo Capital Surplus Fund VIII, L.P. Capital VIII, LLC is the General Partner of Vivo Capital Surplus Fund VIII, L.P. Vivo Capital VIII, LLC disclaims beneficial ownership over such securities except to the extent of its pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes."}],"balance_after":273615,"source":{"system":"sec-edgar","filing":"0001213900-23-088909","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1728970/000121390023088909/ownership.xml","form_type":"4"}},{"id":1734694,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":92274,"kind":"organization","name":"Vivo Capital VIII, LLC","position":1,"cik":"0001618789","reported_name":"Vivo Capital VIII, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":92275,"kind":"organization","name":"Vivo Capital Fund VIII, L.P.","position":2,"cik":"0001618788","reported_name":"Vivo Capital Fund VIII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":92276,"kind":"organization","name":"Vivo Capital Surplus Fund VIII, L.P.","position":3,"cik":"0001628048","reported_name":"Vivo Capital Surplus Fund VIII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":30106,"kind":"organization","name":"Vivo Opportunity, LLC","position":4,"cik":"0001728970","reported_name":"Vivo Opportunity, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":30107,"kind":"organization","name":"Vivo Opportunity Fund Holdings, L.P.","position":5,"cik":"0001930214","reported_name":"Vivo Opportunity Fund Holdings, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":107995,"kind":"organization","name":"Vivo Panda, LLC","position":6,"cik":"0001843847","reported_name":"Vivo Panda, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":107996,"kind":"organization","name":"Vivo Panda Fund, L.P.","position":7,"cik":"0001675490","reported_name":"Vivo Panda Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Comon Stock","published_at":"2023-11-21T02:09:11.000Z","date":"2023-11-17","kind":"sale","planned":false,"acquired":false,"shares":8211,"price":0.93,"value":7636.23,"ownership":{"direct":false,"nature":"By: Vivo Capital Fund VIII, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported herein is a weighted average price. These shares were sold on the open market in multiple transactions at prices ranging from $0.93 to $0.95, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the ranges set forth in footnote (5) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The shares are held of record by Vivo Capital Fund VIII, L.P. Vivo Capital VIII, LLC is the General Partner of Vivo Capital Fund VIII, L.P. Vivo Capital VIII, LLC disclaims beneficial ownership over such securities except to the extent of its pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes."}],"balance_after":1981474,"source":{"system":"sec-edgar","filing":"0001213900-23-088909","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1728970/000121390023088909/ownership.xml","form_type":"4"}},{"id":1734693,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":92274,"kind":"organization","name":"Vivo Capital VIII, LLC","position":1,"cik":"0001618789","reported_name":"Vivo Capital VIII, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":92275,"kind":"organization","name":"Vivo Capital Fund VIII, L.P.","position":2,"cik":"0001618788","reported_name":"Vivo Capital Fund VIII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":92276,"kind":"organization","name":"Vivo Capital Surplus Fund VIII, L.P.","position":3,"cik":"0001628048","reported_name":"Vivo Capital Surplus Fund VIII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":30106,"kind":"organization","name":"Vivo Opportunity, LLC","position":4,"cik":"0001728970","reported_name":"Vivo Opportunity, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":30107,"kind":"organization","name":"Vivo Opportunity Fund Holdings, L.P.","position":5,"cik":"0001930214","reported_name":"Vivo Opportunity Fund Holdings, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":107995,"kind":"organization","name":"Vivo Panda, LLC","position":6,"cik":"0001843847","reported_name":"Vivo Panda, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":107996,"kind":"organization","name":"Vivo Panda Fund, L.P.","position":7,"cik":"0001675490","reported_name":"Vivo Panda Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-11-21T02:09:11.000Z","date":"2023-11-16","kind":"sale","planned":false,"acquired":false,"shares":6429,"price":0.96,"value":6171.84,"ownership":{"direct":false,"nature":"By: Vivo Opportunity Fund Holdings, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported herein is a weighted average price. These shares were sold on the open market in multiple transactions at prices ranging from $0.95 to $0.98, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the ranges set forth in footnote (4) to this Form 4"},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are held of record by Vivo Opportunity Fund Holdings, L.P. Vivo Opportunity, LLC is the General Partner of Vivo Opportunity Holdings, L.P. Vivo Opportunity, LLC disclaims beneficial ownership over such securities except to the extent of its pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes."}],"balance_after":143571,"source":{"system":"sec-edgar","filing":"0001213900-23-088909","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1728970/000121390023088909/ownership.xml","form_type":"4"}},{"id":1734692,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":92274,"kind":"organization","name":"Vivo Capital VIII, LLC","position":1,"cik":"0001618789","reported_name":"Vivo Capital VIII, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":92275,"kind":"organization","name":"Vivo Capital Fund VIII, L.P.","position":2,"cik":"0001618788","reported_name":"Vivo Capital Fund VIII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":92276,"kind":"organization","name":"Vivo Capital Surplus Fund VIII, L.P.","position":3,"cik":"0001628048","reported_name":"Vivo Capital Surplus Fund VIII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":30106,"kind":"organization","name":"Vivo Opportunity, LLC","position":4,"cik":"0001728970","reported_name":"Vivo Opportunity, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":30107,"kind":"organization","name":"Vivo Opportunity Fund Holdings, L.P.","position":5,"cik":"0001930214","reported_name":"Vivo Opportunity Fund Holdings, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":107995,"kind":"organization","name":"Vivo Panda, LLC","position":6,"cik":"0001843847","reported_name":"Vivo Panda, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":107996,"kind":"organization","name":"Vivo Panda Fund, L.P.","position":7,"cik":"0001675490","reported_name":"Vivo Panda Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-11-21T02:09:11.000Z","date":"2023-11-16","kind":"sale","planned":false,"acquired":false,"shares":1040,"price":0.96,"value":998.4,"ownership":{"direct":false,"nature":"By: Vivo Capital Surplus Fund VIII, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported herein is a weighted average price. These shares were sold on the open market in multiple transactions at prices ranging from $0.95 to $0.98, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the ranges set forth in footnote (4) to this Form 4"},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held of record by Vivo Capital Surplus Fund VIII, L.P. Capital VIII, LLC is the General Partner of Vivo Capital Surplus Fund VIII, L.P. Vivo Capital VIII, LLC disclaims beneficial ownership over such securities except to the extent of its pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes."}],"balance_after":274749,"source":{"system":"sec-edgar","filing":"0001213900-23-088909","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1728970/000121390023088909/ownership.xml","form_type":"4"}},{"id":1734691,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":92274,"kind":"organization","name":"Vivo Capital VIII, LLC","position":1,"cik":"0001618789","reported_name":"Vivo Capital VIII, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":92275,"kind":"organization","name":"Vivo Capital Fund VIII, L.P.","position":2,"cik":"0001618788","reported_name":"Vivo Capital Fund VIII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":92276,"kind":"organization","name":"Vivo Capital Surplus Fund VIII, L.P.","position":3,"cik":"0001628048","reported_name":"Vivo Capital Surplus Fund VIII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":30106,"kind":"organization","name":"Vivo Opportunity, LLC","position":4,"cik":"0001728970","reported_name":"Vivo Opportunity, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":30107,"kind":"organization","name":"Vivo Opportunity Fund Holdings, L.P.","position":5,"cik":"0001930214","reported_name":"Vivo Opportunity Fund Holdings, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":107995,"kind":"organization","name":"Vivo Panda, LLC","position":6,"cik":"0001843847","reported_name":"Vivo Panda, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":107996,"kind":"organization","name":"Vivo Panda Fund, L.P.","position":7,"cik":"0001675490","reported_name":"Vivo Panda Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-11-21T02:09:11.000Z","date":"2023-11-16","kind":"sale","planned":false,"acquired":false,"shares":7531,"price":0.96,"value":7229.76,"ownership":{"direct":false,"nature":"By: Vivo Capital Fund VIII, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported herein is a weighted average price. These shares were sold on the open market in multiple transactions at prices ranging from $0.95 to $0.98, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the ranges set forth in footnote (4) to this Form 4"},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The shares are held of record by Vivo Capital Fund VIII, L.P. Vivo Capital VIII, LLC is the General Partner of Vivo Capital Fund VIII, L.P. Vivo Capital VIII, LLC disclaims beneficial ownership over such securities except to the extent of its pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes."}],"balance_after":1989685,"source":{"system":"sec-edgar","filing":"0001213900-23-088909","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1728970/000121390023088909/ownership.xml","form_type":"4"}},{"id":2872094,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":92274,"kind":"organization","name":"Vivo Capital VIII, LLC","position":1,"cik":"0001618789","reported_name":"Vivo Capital VIII, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":92275,"kind":"organization","name":"Vivo Capital Fund VIII, L.P.","position":2,"cik":"0001618788","reported_name":"Vivo Capital Fund VIII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":92276,"kind":"organization","name":"Vivo Capital Surplus Fund VIII, L.P.","position":3,"cik":"0001628048","reported_name":"Vivo Capital Surplus Fund VIII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":107996,"kind":"organization","name":"Vivo Panda Fund, L.P.","position":4,"cik":"0001675490","reported_name":"Vivo Panda Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":107995,"kind":"organization","name":"Vivo Panda, LLC","position":5,"cik":"0001843847","reported_name":"Vivo Panda, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":130985,"kind":"organization","name":"Vivo Opportunity Fund, L.P.","position":6,"cik":"0001726403","reported_name":"Vivo Opportunity Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":30106,"kind":"organization","name":"Vivo Opportunity, LLC","position":7,"cik":"0001728970","reported_name":"Vivo Opportunity, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant (Right to Buy)","published_at":"2021-02-09T20:37:46.000Z","date":"2021-02-09","kind":"other","acquired":false,"shares":5655,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Vivo Capital Surplus Fund VIII, L.P."},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F12","text":"The shares subject to this warrant were fully vested prior to exercise."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F9","text":"The securities reported herein are held of record by Vivo Capital Surplus Fund VIII, L.P. Vivo Capital VIII, LLC is the general partner of Vivo Capital Fund VIII, L.P. Edgar Engleman is one of three voting members of Vivo Capital VIII, LLC."}],"balance_after":0,"derivative":{"exercise_price":0.07,"expiration_date":"2028-07-26","underlying":"Common Stock","underlying_shares":5655},"source":{"system":"sec-edgar","filing":"0001209191-21-008758","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":28,"url":"https://www.sec.gov/Archives/edgar/data/1728970/000120919121008758/doc4.xml","form_type":"4"}},{"id":2872093,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":92274,"kind":"organization","name":"Vivo Capital VIII, LLC","position":1,"cik":"0001618789","reported_name":"Vivo Capital VIII, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":92275,"kind":"organization","name":"Vivo Capital Fund VIII, L.P.","position":2,"cik":"0001618788","reported_name":"Vivo Capital Fund VIII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":92276,"kind":"organization","name":"Vivo Capital Surplus Fund VIII, L.P.","position":3,"cik":"0001628048","reported_name":"Vivo Capital Surplus Fund VIII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":107996,"kind":"organization","name":"Vivo Panda Fund, L.P.","position":4,"cik":"0001675490","reported_name":"Vivo Panda Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":107995,"kind":"organization","name":"Vivo Panda, LLC","position":5,"cik":"0001843847","reported_name":"Vivo Panda, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":130985,"kind":"organization","name":"Vivo Opportunity Fund, L.P.","position":6,"cik":"0001726403","reported_name":"Vivo Opportunity Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":30106,"kind":"organization","name":"Vivo Opportunity, LLC","position":7,"cik":"0001728970","reported_name":"Vivo Opportunity, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C-2 Preferred Stock","published_at":"2021-02-09T20:37:46.000Z","date":"2021-02-09","kind":"exercise","acquired":false,"shares":47718,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Vivo Capital Surplus Fund VIII, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"The Series C-2 Preferred Stock automatically converted into shares of Common Stock of the Issuer on a 1:1 basis immediately upon closing of the Issuer's IPO and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The Series C-2 Preferred Stock automatically converted into shares of Common Stock of the Issuer on a 1:1 basis immediately upon closing of the Issuer's IPO and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"The Series C-2 Preferred Stock automatically converted into shares of Common Stock of the Issuer on a 1:1 basis immediately upon closing of the Issuer's IPO and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F9","text":"The securities reported herein are held of record by Vivo Capital Surplus Fund VIII, L.P. Vivo Capital VIII, LLC is the general partner of Vivo Capital Fund VIII, L.P. Edgar Engleman is one of three voting members of Vivo Capital VIII, LLC."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":47718},"source":{"system":"sec-edgar","filing":"0001209191-21-008758","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":27,"url":"https://www.sec.gov/Archives/edgar/data/1728970/000120919121008758/doc4.xml","form_type":"4"}},{"id":2872092,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":92274,"kind":"organization","name":"Vivo Capital VIII, LLC","position":1,"cik":"0001618789","reported_name":"Vivo Capital VIII, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":92275,"kind":"organization","name":"Vivo Capital Fund VIII, L.P.","position":2,"cik":"0001618788","reported_name":"Vivo Capital Fund VIII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":92276,"kind":"organization","name":"Vivo Capital Surplus Fund VIII, L.P.","position":3,"cik":"0001628048","reported_name":"Vivo Capital Surplus Fund VIII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":107996,"kind":"organization","name":"Vivo Panda Fund, L.P.","position":4,"cik":"0001675490","reported_name":"Vivo Panda Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":107995,"kind":"organization","name":"Vivo Panda, LLC","position":5,"cik":"0001843847","reported_name":"Vivo Panda, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":130985,"kind":"organization","name":"Vivo Opportunity Fund, L.P.","position":6,"cik":"0001726403","reported_name":"Vivo Opportunity Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":30106,"kind":"organization","name":"Vivo Opportunity, LLC","position":7,"cik":"0001728970","reported_name":"Vivo Opportunity, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C-1 Preferred Stock","published_at":"2021-02-09T20:37:46.000Z","date":"2021-02-09","kind":"exercise","acquired":false,"shares":43901,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Vivo Capital Surplus Fund VIII, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"The Series C-1 Preferred Stock automatically converted into shares of Common Stock of the Issuer on a 1:1 basis immediately upon closing of the Issuer's IPO and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The Series C-1 Preferred Stock automatically converted into shares of Common Stock of the Issuer on a 1:1 basis immediately upon closing of the Issuer's IPO and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"The Series C-1 Preferred Stock automatically converted into shares of Common Stock of the Issuer on a 1:1 basis immediately upon closing of the Issuer's IPO and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F9","text":"The securities reported herein are held of record by Vivo Capital Surplus Fund VIII, L.P. Vivo Capital VIII, LLC is the general partner of Vivo Capital Fund VIII, L.P. Edgar Engleman is one of three voting members of Vivo Capital VIII, LLC."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":43901},"source":{"system":"sec-edgar","filing":"0001209191-21-008758","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":26,"url":"https://www.sec.gov/Archives/edgar/data/1728970/000120919121008758/doc4.xml","form_type":"4"}},{"id":2872091,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":92274,"kind":"organization","name":"Vivo Capital VIII, LLC","position":1,"cik":"0001618789","reported_name":"Vivo Capital VIII, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":92275,"kind":"organization","name":"Vivo Capital Fund VIII, L.P.","position":2,"cik":"0001618788","reported_name":"Vivo Capital Fund VIII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":92276,"kind":"organization","name":"Vivo Capital Surplus Fund VIII, L.P.","position":3,"cik":"0001628048","reported_name":"Vivo Capital Surplus Fund VIII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":107996,"kind":"organization","name":"Vivo Panda Fund, L.P.","position":4,"cik":"0001675490","reported_name":"Vivo Panda Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":107995,"kind":"organization","name":"Vivo Panda, LLC","position":5,"cik":"0001843847","reported_name":"Vivo Panda, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":130985,"kind":"organization","name":"Vivo Opportunity Fund, L.P.","position":6,"cik":"0001726403","reported_name":"Vivo Opportunity Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":30106,"kind":"organization","name":"Vivo Opportunity, LLC","position":7,"cik":"0001728970","reported_name":"Vivo Opportunity, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Preferred Stock","published_at":"2021-02-09T20:37:46.000Z","date":"2021-02-09","kind":"exercise","acquired":false,"shares":150802,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Vivo Capital Surplus Fund VIII, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The Series B Preferred Stock automatically converted into shares of Common Stock of the Issuer on a 1:1 basis immediately upon closing of the Issuer's IPO and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Series B Preferred Stock automatically converted into shares of Common Stock of the Issuer on a 1:1 basis immediately upon closing of the Issuer's IPO and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The Series B Preferred Stock automatically converted into shares of Common Stock of the Issuer on a 1:1 basis immediately upon closing of the Issuer's IPO and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F9","text":"The securities reported herein are held of record by Vivo Capital Surplus Fund VIII, L.P. Vivo Capital VIII, LLC is the general partner of Vivo Capital Fund VIII, L.P. Edgar Engleman is one of three voting members of Vivo Capital VIII, LLC."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":150802},"source":{"system":"sec-edgar","filing":"0001209191-21-008758","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":25,"url":"https://www.sec.gov/Archives/edgar/data/1728970/000120919121008758/doc4.xml","form_type":"4"}},{"id":2872090,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":92274,"kind":"organization","name":"Vivo Capital VIII, LLC","position":1,"cik":"0001618789","reported_name":"Vivo Capital VIII, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":92275,"kind":"organization","name":"Vivo Capital Fund VIII, L.P.","position":2,"cik":"0001618788","reported_name":"Vivo Capital Fund VIII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":92276,"kind":"organization","name":"Vivo Capital Surplus Fund VIII, L.P.","position":3,"cik":"0001628048","reported_name":"Vivo Capital Surplus Fund VIII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":107996,"kind":"organization","name":"Vivo Panda Fund, L.P.","position":4,"cik":"0001675490","reported_name":"Vivo Panda Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":107995,"kind":"organization","name":"Vivo Panda, LLC","position":5,"cik":"0001843847","reported_name":"Vivo Panda, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":130985,"kind":"organization","name":"Vivo Opportunity Fund, L.P.","position":6,"cik":"0001726403","reported_name":"Vivo Opportunity Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":30106,"kind":"organization","name":"Vivo Opportunity, LLC","position":7,"cik":"0001728970","reported_name":"Vivo Opportunity, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant (Right to Buy)","published_at":"2021-02-09T20:37:46.000Z","date":"2021-02-09","kind":"other","acquired":false,"shares":40953,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Vivo Capital Fund VIII, L.P."},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F12","text":"The shares subject to this warrant were fully vested prior to exercise."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"The securities reported herein are held of record by Vivo Capital Fund VIII, L.P. Vivo Capital VIII, LLC is the general partner of Vivo Capital Fund VIII, L.P. Edgar Engleman is one of three voting members of Vivo Capital VIII, LLC."}],"balance_after":0,"derivative":{"exercise_price":0.07,"expiration_date":"2028-07-26","underlying":"Common Stock","underlying_shares":40953},"source":{"system":"sec-edgar","filing":"0001209191-21-008758","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":24,"url":"https://www.sec.gov/Archives/edgar/data/1728970/000120919121008758/doc4.xml","form_type":"4"}},{"id":2872089,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":92274,"kind":"organization","name":"Vivo Capital VIII, LLC","position":1,"cik":"0001618789","reported_name":"Vivo Capital VIII, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":92275,"kind":"organization","name":"Vivo Capital Fund VIII, L.P.","position":2,"cik":"0001618788","reported_name":"Vivo Capital Fund VIII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":92276,"kind":"organization","name":"Vivo Capital Surplus Fund VIII, L.P.","position":3,"cik":"0001628048","reported_name":"Vivo Capital Surplus Fund VIII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":107996,"kind":"organization","name":"Vivo Panda Fund, L.P.","position":4,"cik":"0001675490","reported_name":"Vivo Panda Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":107995,"kind":"organization","name":"Vivo Panda, LLC","position":5,"cik":"0001843847","reported_name":"Vivo Panda, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":130985,"kind":"organization","name":"Vivo Opportunity Fund, L.P.","position":6,"cik":"0001726403","reported_name":"Vivo Opportunity Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":30106,"kind":"organization","name":"Vivo Opportunity, LLC","position":7,"cik":"0001728970","reported_name":"Vivo Opportunity, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C-2 Preferred Stock","published_at":"2021-02-09T20:37:46.000Z","date":"2021-02-09","kind":"exercise","acquired":false,"shares":345568,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Vivo Capital Fund VIII, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"The Series C-2 Preferred Stock automatically converted into shares of Common Stock of the Issuer on a 1:1 basis immediately upon closing of the Issuer's IPO and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The Series C-2 Preferred Stock automatically converted into shares of Common Stock of the Issuer on a 1:1 basis immediately upon closing of the Issuer's IPO and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"The Series C-2 Preferred Stock automatically converted into shares of Common Stock of the Issuer on a 1:1 basis immediately upon closing of the Issuer's IPO and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"The securities reported herein are held of record by Vivo Capital Fund VIII, L.P. Vivo Capital VIII, LLC is the general partner of Vivo Capital Fund VIII, L.P. Edgar Engleman is one of three voting members of Vivo Capital VIII, LLC."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":345568},"source":{"system":"sec-edgar","filing":"0001209191-21-008758","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":23,"url":"https://www.sec.gov/Archives/edgar/data/1728970/000120919121008758/doc4.xml","form_type":"4"}},{"id":2872088,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":92274,"kind":"organization","name":"Vivo Capital VIII, LLC","position":1,"cik":"0001618789","reported_name":"Vivo Capital VIII, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":92275,"kind":"organization","name":"Vivo Capital Fund VIII, L.P.","position":2,"cik":"0001618788","reported_name":"Vivo Capital Fund VIII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":92276,"kind":"organization","name":"Vivo Capital Surplus Fund VIII, L.P.","position":3,"cik":"0001628048","reported_name":"Vivo Capital Surplus Fund VIII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":107996,"kind":"organization","name":"Vivo Panda Fund, L.P.","position":4,"cik":"0001675490","reported_name":"Vivo Panda Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":107995,"kind":"organization","name":"Vivo Panda, LLC","position":5,"cik":"0001843847","reported_name":"Vivo Panda, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":130985,"kind":"organization","name":"Vivo Opportunity Fund, L.P.","position":6,"cik":"0001726403","reported_name":"Vivo Opportunity Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":30106,"kind":"organization","name":"Vivo Opportunity, LLC","position":7,"cik":"0001728970","reported_name":"Vivo Opportunity, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C-1 Preferred Stock","published_at":"2021-02-09T20:37:46.000Z","date":"2021-02-09","kind":"exercise","acquired":false,"shares":317922,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Vivo Capital Fund VIII, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"The Series C-1 Preferred Stock automatically converted into shares of Common Stock of the Issuer on a 1:1 basis immediately upon closing of the Issuer's IPO and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The Series C-1 Preferred Stock automatically converted into shares of Common Stock of the Issuer on a 1:1 basis immediately upon closing of the Issuer's IPO and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"The Series C-1 Preferred Stock automatically converted into shares of Common Stock of the Issuer on a 1:1 basis immediately upon closing of the Issuer's IPO and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"The securities reported herein are held of record by Vivo Capital Fund VIII, L.P. Vivo Capital VIII, LLC is the general partner of Vivo Capital Fund VIII, L.P. Edgar Engleman is one of three voting members of Vivo Capital VIII, LLC."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":317922},"source":{"system":"sec-edgar","filing":"0001209191-21-008758","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":22,"url":"https://www.sec.gov/Archives/edgar/data/1728970/000120919121008758/doc4.xml","form_type":"4"}},{"id":2872087,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":92274,"kind":"organization","name":"Vivo Capital VIII, LLC","position":1,"cik":"0001618789","reported_name":"Vivo Capital VIII, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":92275,"kind":"organization","name":"Vivo Capital Fund VIII, L.P.","position":2,"cik":"0001618788","reported_name":"Vivo Capital Fund VIII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":92276,"kind":"organization","name":"Vivo Capital Surplus Fund VIII, L.P.","position":3,"cik":"0001628048","reported_name":"Vivo Capital Surplus Fund VIII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":107996,"kind":"organization","name":"Vivo Panda Fund, L.P.","position":4,"cik":"0001675490","reported_name":"Vivo Panda Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":107995,"kind":"organization","name":"Vivo Panda, LLC","position":5,"cik":"0001843847","reported_name":"Vivo Panda, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":130985,"kind":"organization","name":"Vivo Opportunity Fund, L.P.","position":6,"cik":"0001726403","reported_name":"Vivo Opportunity Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":30106,"kind":"organization","name":"Vivo Opportunity, LLC","position":7,"cik":"0001728970","reported_name":"Vivo Opportunity, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Preferred Stock","published_at":"2021-02-09T20:37:46.000Z","date":"2021-02-09","kind":"exercise","acquired":false,"shares":1092080,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Vivo Capital Fund VIII, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The Series B Preferred Stock automatically converted into shares of Common Stock of the Issuer on a 1:1 basis immediately upon closing of the Issuer's IPO and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Series B Preferred Stock automatically converted into shares of Common Stock of the Issuer on a 1:1 basis immediately upon closing of the Issuer's IPO and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The Series B Preferred Stock automatically converted into shares of Common Stock of the Issuer on a 1:1 basis immediately upon closing of the Issuer's IPO and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"The securities reported herein are held of record by Vivo Capital Fund VIII, L.P. Vivo Capital VIII, LLC is the general partner of Vivo Capital Fund VIII, L.P. Edgar Engleman is one of three voting members of Vivo Capital VIII, LLC."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1092080},"source":{"system":"sec-edgar","filing":"0001209191-21-008758","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":21,"url":"https://www.sec.gov/Archives/edgar/data/1728970/000120919121008758/doc4.xml","form_type":"4"}},{"id":2872086,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":92274,"kind":"organization","name":"Vivo Capital VIII, LLC","position":1,"cik":"0001618789","reported_name":"Vivo Capital VIII, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":92275,"kind":"organization","name":"Vivo Capital Fund VIII, L.P.","position":2,"cik":"0001618788","reported_name":"Vivo Capital Fund VIII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":92276,"kind":"organization","name":"Vivo Capital Surplus Fund VIII, L.P.","position":3,"cik":"0001628048","reported_name":"Vivo Capital Surplus Fund VIII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":107996,"kind":"organization","name":"Vivo Panda Fund, L.P.","position":4,"cik":"0001675490","reported_name":"Vivo Panda Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":107995,"kind":"organization","name":"Vivo Panda, LLC","position":5,"cik":"0001843847","reported_name":"Vivo Panda, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":130985,"kind":"organization","name":"Vivo Opportunity Fund, L.P.","position":6,"cik":"0001726403","reported_name":"Vivo Opportunity Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":30106,"kind":"organization","name":"Vivo Opportunity, LLC","position":7,"cik":"0001728970","reported_name":"Vivo Opportunity, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant (Right to Buy)","published_at":"2021-02-09T20:37:46.000Z","date":"2021-02-09","kind":"other","acquired":false,"shares":17711,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Vivo PANDA Fund, L.P."},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F12","text":"The shares subject to this warrant were fully vested prior to exercise."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities reported herein are held of record by Vivo PANDA Fund, L.P. (\"Vivo LP\"). Vivo Panda, LLC (\"Vivo LLC\") is the sole general partner of Vivo LP. Mahendra G. Shah, Ph.D. is one of four voting members of Vivo LLC."}],"balance_after":0,"derivative":{"exercise_price":0.07,"expiration_date":"2028-07-26","underlying":"Common Stock","underlying_shares":17711},"source":{"system":"sec-edgar","filing":"0001209191-21-008758","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":20,"url":"https://www.sec.gov/Archives/edgar/data/1728970/000120919121008758/doc4.xml","form_type":"4"}},{"id":2872085,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":92274,"kind":"organization","name":"Vivo Capital VIII, LLC","position":1,"cik":"0001618789","reported_name":"Vivo Capital VIII, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":92275,"kind":"organization","name":"Vivo Capital Fund VIII, L.P.","position":2,"cik":"0001618788","reported_name":"Vivo Capital Fund VIII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":92276,"kind":"organization","name":"Vivo Capital Surplus Fund VIII, L.P.","position":3,"cik":"0001628048","reported_name":"Vivo Capital Surplus Fund VIII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":107996,"kind":"organization","name":"Vivo Panda Fund, L.P.","position":4,"cik":"0001675490","reported_name":"Vivo Panda Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":107995,"kind":"organization","name":"Vivo Panda, LLC","position":5,"cik":"0001843847","reported_name":"Vivo Panda, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":130985,"kind":"organization","name":"Vivo Opportunity Fund, L.P.","position":6,"cik":"0001726403","reported_name":"Vivo Opportunity Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":30106,"kind":"organization","name":"Vivo Opportunity, LLC","position":7,"cik":"0001728970","reported_name":"Vivo Opportunity, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Preferred Stock","published_at":"2021-02-09T20:37:46.000Z","date":"2021-02-09","kind":"exercise","acquired":false,"shares":472296,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Vivo PANDA Fund, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The Series B Preferred Stock automatically converted into shares of Common Stock of the Issuer on a 1:1 basis immediately upon closing of the Issuer's IPO and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Series B Preferred Stock automatically converted into shares of Common Stock of the Issuer on a 1:1 basis immediately upon closing of the Issuer's IPO and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The Series B Preferred Stock automatically converted into shares of Common Stock of the Issuer on a 1:1 basis immediately upon closing of the Issuer's IPO and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities reported herein are held of record by Vivo PANDA Fund, L.P. (\"Vivo LP\"). Vivo Panda, LLC (\"Vivo LLC\") is the sole general partner of Vivo LP. Mahendra G. Shah, Ph.D. is one of four voting members of Vivo LLC."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":472296},"source":{"system":"sec-edgar","filing":"0001209191-21-008758","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":19,"url":"https://www.sec.gov/Archives/edgar/data/1728970/000120919121008758/doc4.xml","form_type":"4"}},{"id":2872084,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":92274,"kind":"organization","name":"Vivo Capital VIII, LLC","position":1,"cik":"0001618789","reported_name":"Vivo Capital VIII, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":92275,"kind":"organization","name":"Vivo Capital Fund VIII, L.P.","position":2,"cik":"0001618788","reported_name":"Vivo Capital Fund VIII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":92276,"kind":"organization","name":"Vivo Capital Surplus Fund VIII, L.P.","position":3,"cik":"0001628048","reported_name":"Vivo Capital Surplus Fund VIII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":107996,"kind":"organization","name":"Vivo Panda Fund, L.P.","position":4,"cik":"0001675490","reported_name":"Vivo Panda Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":107995,"kind":"organization","name":"Vivo Panda, LLC","position":5,"cik":"0001843847","reported_name":"Vivo Panda, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":130985,"kind":"organization","name":"Vivo Opportunity Fund, L.P.","position":6,"cik":"0001726403","reported_name":"Vivo Opportunity Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":30106,"kind":"organization","name":"Vivo Opportunity, LLC","position":7,"cik":"0001728970","reported_name":"Vivo Opportunity, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A-1 Preferred Stock","published_at":"2021-02-09T20:37:46.000Z","date":"2021-02-09","kind":"exercise","acquired":false,"shares":944056,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Vivo PANDA Fund, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Series A-1 Preferred Stock automatically converted into shares of Common Stock of the Issuer on a 1:1 basis immediately upon closing of\nthe Issuer's initial public offering (the \"IPO\") and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Series A-1 Preferred Stock automatically converted into shares of Common Stock of the Issuer on a 1:1 basis immediately upon closing of\nthe Issuer's initial public offering (the \"IPO\") and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Series A-1 Preferred Stock automatically converted into shares of Common Stock of the Issuer on a 1:1 basis immediately upon closing of\nthe Issuer's initial public offering (the \"IPO\") and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities reported herein are held of record by Vivo PANDA Fund, L.P. (\"Vivo LP\"). Vivo Panda, LLC (\"Vivo LLC\") is the sole general partner of Vivo LP. Mahendra G. Shah, Ph.D. is one of four voting members of Vivo LLC."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":944056},"source":{"system":"sec-edgar","filing":"0001209191-21-008758","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/1728970/000120919121008758/doc4.xml","form_type":"4"}},{"id":2872083,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":92274,"kind":"organization","name":"Vivo Capital VIII, LLC","position":1,"cik":"0001618789","reported_name":"Vivo Capital VIII, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":92275,"kind":"organization","name":"Vivo Capital Fund VIII, L.P.","position":2,"cik":"0001618788","reported_name":"Vivo Capital Fund VIII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":92276,"kind":"organization","name":"Vivo Capital Surplus Fund VIII, L.P.","position":3,"cik":"0001628048","reported_name":"Vivo Capital Surplus Fund VIII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":107996,"kind":"organization","name":"Vivo Panda Fund, L.P.","position":4,"cik":"0001675490","reported_name":"Vivo Panda Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":107995,"kind":"organization","name":"Vivo Panda, LLC","position":5,"cik":"0001843847","reported_name":"Vivo Panda, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":130985,"kind":"organization","name":"Vivo Opportunity Fund, L.P.","position":6,"cik":"0001726403","reported_name":"Vivo Opportunity Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":30106,"kind":"organization","name":"Vivo Opportunity, LLC","position":7,"cik":"0001728970","reported_name":"Vivo Opportunity, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-02-09T20:37:46.000Z","date":"2021-02-09","kind":"purchase","acquired":true,"shares":150000,"price":20,"value":3000000.0,"ownership":{"direct":false,"nature":"By Vivo Opportunity Fund, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F11","text":"The shares are held of record by Vivo Opportunity Fund, L.P. (VOF). Vivo Opportunity, LLC is the general partner of VOF and has four managing members."}],"balance_after":150000,"source":{"system":"sec-edgar","filing":"0001209191-21-008758","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1728970/000120919121008758/doc4.xml","form_type":"4"}},{"id":2872082,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":92274,"kind":"organization","name":"Vivo Capital VIII, LLC","position":1,"cik":"0001618789","reported_name":"Vivo Capital VIII, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":92275,"kind":"organization","name":"Vivo Capital Fund VIII, L.P.","position":2,"cik":"0001618788","reported_name":"Vivo Capital Fund VIII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":92276,"kind":"organization","name":"Vivo Capital Surplus Fund VIII, L.P.","position":3,"cik":"0001628048","reported_name":"Vivo Capital Surplus Fund VIII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":107996,"kind":"organization","name":"Vivo Panda Fund, L.P.","position":4,"cik":"0001675490","reported_name":"Vivo Panda Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":107995,"kind":"organization","name":"Vivo Panda, LLC","position":5,"cik":"0001843847","reported_name":"Vivo Panda, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":130985,"kind":"organization","name":"Vivo Opportunity Fund, L.P.","position":6,"cik":"0001726403","reported_name":"Vivo Opportunity Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":30106,"kind":"organization","name":"Vivo Opportunity, LLC","position":7,"cik":"0001728970","reported_name":"Vivo Opportunity, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-02-09T20:37:46.000Z","date":"2021-02-09","kind":"purchase","acquired":true,"shares":24267,"price":20,"value":485340.0,"ownership":{"direct":false,"nature":"By Vivo Capital Surplus Fund VIII, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F9","text":"The securities reported herein are held of record by Vivo Capital Surplus Fund VIII, L.P. Vivo Capital VIII, LLC is the general partner of Vivo Capital Fund VIII, L.P. Edgar Engleman is one of three voting members of Vivo Capital VIII, LLC."}],"balance_after":275789,"source":{"system":"sec-edgar","filing":"0001209191-21-008758","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1728970/000120919121008758/doc4.xml","form_type":"4"}},{"id":2872081,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":92274,"kind":"organization","name":"Vivo Capital VIII, LLC","position":1,"cik":"0001618789","reported_name":"Vivo Capital VIII, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":92275,"kind":"organization","name":"Vivo Capital Fund VIII, L.P.","position":2,"cik":"0001618788","reported_name":"Vivo Capital Fund VIII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":92276,"kind":"organization","name":"Vivo Capital Surplus Fund VIII, L.P.","position":3,"cik":"0001628048","reported_name":"Vivo Capital Surplus Fund VIII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":107996,"kind":"organization","name":"Vivo Panda Fund, L.P.","position":4,"cik":"0001675490","reported_name":"Vivo Panda Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":107995,"kind":"organization","name":"Vivo Panda, LLC","position":5,"cik":"0001843847","reported_name":"Vivo Panda, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":130985,"kind":"organization","name":"Vivo Opportunity Fund, L.P.","position":6,"cik":"0001726403","reported_name":"Vivo Opportunity Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":30106,"kind":"organization","name":"Vivo Opportunity, LLC","position":7,"cik":"0001728970","reported_name":"Vivo Opportunity, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-02-09T20:37:46.000Z","date":"2021-02-09","kind":"sale","acquired":false,"shares":20,"price":20,"value":400.0,"ownership":{"direct":false,"nature":"By Vivo Capital Surplus Fund VIII, L.P."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F10","text":"Upon closing of the Issuer's IPO, Vivo Capital Surplus Fund VIII, L.P. exercised a warrant to purchase 5,655 shares of the Issuer's Common Stock at an exercise price per share of $0.07. Vivo Capital Surplus Fund VIII, L.P. paid the exercise price on a cashless basis, resulting in the Issuer withholding 20 share subject to the warrant in order to pay the exercise price and issuing to Vivo Capital Surplus Fund VIII, L.P. the remaining 5,635 shares of Common Stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F9","text":"The securities reported herein are held of record by Vivo Capital Surplus Fund VIII, L.P. Vivo Capital VIII, LLC is the general partner of Vivo Capital Fund VIII, L.P. Edgar Engleman is one of three voting members of Vivo Capital VIII, LLC."}],"balance_after":251522,"source":{"system":"sec-edgar","filing":"0001209191-21-008758","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1728970/000120919121008758/doc4.xml","form_type":"4"}},{"id":2872080,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":92274,"kind":"organization","name":"Vivo Capital VIII, LLC","position":1,"cik":"0001618789","reported_name":"Vivo Capital VIII, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":92275,"kind":"organization","name":"Vivo Capital Fund VIII, L.P.","position":2,"cik":"0001618788","reported_name":"Vivo Capital Fund VIII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":92276,"kind":"organization","name":"Vivo Capital Surplus Fund VIII, L.P.","position":3,"cik":"0001628048","reported_name":"Vivo Capital Surplus Fund VIII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":107996,"kind":"organization","name":"Vivo Panda Fund, L.P.","position":4,"cik":"0001675490","reported_name":"Vivo Panda Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":107995,"kind":"organization","name":"Vivo Panda, LLC","position":5,"cik":"0001843847","reported_name":"Vivo Panda, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":130985,"kind":"organization","name":"Vivo Opportunity Fund, L.P.","position":6,"cik":"0001726403","reported_name":"Vivo Opportunity Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":30106,"kind":"organization","name":"Vivo Opportunity, LLC","position":7,"cik":"0001728970","reported_name":"Vivo Opportunity, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-02-09T20:37:46.000Z","date":"2021-02-09","kind":"other","acquired":true,"shares":5655,"price":0.07,"value":395.85,"ownership":{"direct":false,"nature":"By Vivo Capital Surplus Fund VIII, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F9","text":"The securities reported herein are held of record by Vivo Capital Surplus Fund VIII, L.P. Vivo Capital VIII, LLC is the general partner of Vivo Capital Fund VIII, L.P. Edgar Engleman is one of three voting members of Vivo Capital VIII, LLC."}],"balance_after":251542,"source":{"system":"sec-edgar","filing":"0001209191-21-008758","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1728970/000120919121008758/doc4.xml","form_type":"4"}},{"id":2872079,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":92274,"kind":"organization","name":"Vivo Capital VIII, LLC","position":1,"cik":"0001618789","reported_name":"Vivo Capital VIII, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":92275,"kind":"organization","name":"Vivo Capital Fund VIII, L.P.","position":2,"cik":"0001618788","reported_name":"Vivo Capital Fund VIII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":92276,"kind":"organization","name":"Vivo Capital Surplus Fund VIII, L.P.","position":3,"cik":"0001628048","reported_name":"Vivo Capital Surplus Fund VIII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":107996,"kind":"organization","name":"Vivo Panda Fund, L.P.","position":4,"cik":"0001675490","reported_name":"Vivo Panda Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":107995,"kind":"organization","name":"Vivo Panda, LLC","position":5,"cik":"0001843847","reported_name":"Vivo Panda, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":130985,"kind":"organization","name":"Vivo Opportunity Fund, L.P.","position":6,"cik":"0001726403","reported_name":"Vivo Opportunity Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":30106,"kind":"organization","name":"Vivo Opportunity, LLC","position":7,"cik":"0001728970","reported_name":"Vivo Opportunity, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-02-09T20:37:46.000Z","date":"2021-02-09","kind":"exercise","acquired":true,"shares":47718,"ownership":{"direct":false,"nature":"By Vivo Capital Surplus Fund VIII, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The Series C-2 Preferred Stock automatically converted into shares of Common Stock of the Issuer on a 1:1 basis immediately upon closing of the Issuer's IPO and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F9","text":"The securities reported herein are held of record by Vivo Capital Surplus Fund VIII, L.P. Vivo Capital VIII, LLC is the general partner of Vivo Capital Fund VIII, L.P. Edgar Engleman is one of three voting members of Vivo Capital VIII, LLC."}],"balance_after":245887,"source":{"system":"sec-edgar","filing":"0001209191-21-008758","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1728970/000120919121008758/doc4.xml","form_type":"4"}},{"id":2872078,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":92274,"kind":"organization","name":"Vivo Capital VIII, LLC","position":1,"cik":"0001618789","reported_name":"Vivo Capital VIII, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":92275,"kind":"organization","name":"Vivo Capital Fund VIII, L.P.","position":2,"cik":"0001618788","reported_name":"Vivo Capital Fund VIII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":92276,"kind":"organization","name":"Vivo Capital Surplus Fund VIII, L.P.","position":3,"cik":"0001628048","reported_name":"Vivo Capital Surplus Fund VIII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":107996,"kind":"organization","name":"Vivo Panda Fund, L.P.","position":4,"cik":"0001675490","reported_name":"Vivo Panda Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":107995,"kind":"organization","name":"Vivo Panda, LLC","position":5,"cik":"0001843847","reported_name":"Vivo Panda, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":130985,"kind":"organization","name":"Vivo Opportunity Fund, L.P.","position":6,"cik":"0001726403","reported_name":"Vivo Opportunity Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":30106,"kind":"organization","name":"Vivo Opportunity, LLC","position":7,"cik":"0001728970","reported_name":"Vivo Opportunity, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-02-09T20:37:46.000Z","date":"2021-02-09","kind":"exercise","acquired":true,"shares":43901,"ownership":{"direct":false,"nature":"By Vivo Capital Surplus Fund VIII, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The Series C-1 Preferred Stock automatically converted into shares of Common Stock of the Issuer on a 1:1 basis immediately upon closing of the Issuer's IPO and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F9","text":"The securities reported herein are held of record by Vivo Capital Surplus Fund VIII, L.P. Vivo Capital VIII, LLC is the general partner of Vivo Capital Fund VIII, L.P. Edgar Engleman is one of three voting members of Vivo Capital VIII, LLC."}],"balance_after":198169,"source":{"system":"sec-edgar","filing":"0001209191-21-008758","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1728970/000120919121008758/doc4.xml","form_type":"4"}},{"id":2872077,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":92274,"kind":"organization","name":"Vivo Capital VIII, LLC","position":1,"cik":"0001618789","reported_name":"Vivo Capital VIII, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":92275,"kind":"organization","name":"Vivo Capital Fund VIII, L.P.","position":2,"cik":"0001618788","reported_name":"Vivo Capital Fund VIII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":92276,"kind":"organization","name":"Vivo Capital Surplus Fund VIII, L.P.","position":3,"cik":"0001628048","reported_name":"Vivo Capital Surplus Fund VIII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":107996,"kind":"organization","name":"Vivo Panda Fund, L.P.","position":4,"cik":"0001675490","reported_name":"Vivo Panda Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":107995,"kind":"organization","name":"Vivo Panda, LLC","position":5,"cik":"0001843847","reported_name":"Vivo Panda, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":130985,"kind":"organization","name":"Vivo Opportunity Fund, L.P.","position":6,"cik":"0001726403","reported_name":"Vivo Opportunity Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":30106,"kind":"organization","name":"Vivo Opportunity, LLC","position":7,"cik":"0001728970","reported_name":"Vivo Opportunity, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-02-09T20:37:46.000Z","date":"2021-02-09","kind":"exercise","acquired":true,"shares":150802,"ownership":{"direct":false,"nature":"By Vivo Capital Surplus Fund VIII, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The Series B Preferred Stock automatically converted into shares of Common Stock of the Issuer on a 1:1 basis immediately upon closing of the Issuer's IPO and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F9","text":"The securities reported herein are held of record by Vivo Capital Surplus Fund VIII, L.P. Vivo Capital VIII, LLC is the general partner of Vivo Capital Fund VIII, L.P. Edgar Engleman is one of three voting members of Vivo Capital VIII, LLC."}],"balance_after":154268,"source":{"system":"sec-edgar","filing":"0001209191-21-008758","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1728970/000120919121008758/doc4.xml","form_type":"4"}},{"id":2872076,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":92274,"kind":"organization","name":"Vivo Capital VIII, LLC","position":1,"cik":"0001618789","reported_name":"Vivo Capital VIII, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":92275,"kind":"organization","name":"Vivo Capital Fund VIII, L.P.","position":2,"cik":"0001618788","reported_name":"Vivo Capital Fund VIII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":92276,"kind":"organization","name":"Vivo Capital Surplus Fund VIII, L.P.","position":3,"cik":"0001628048","reported_name":"Vivo Capital Surplus Fund VIII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":107996,"kind":"organization","name":"Vivo Panda Fund, L.P.","position":4,"cik":"0001675490","reported_name":"Vivo Panda Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":107995,"kind":"organization","name":"Vivo Panda, LLC","position":5,"cik":"0001843847","reported_name":"Vivo Panda, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":130985,"kind":"organization","name":"Vivo Opportunity Fund, L.P.","position":6,"cik":"0001726403","reported_name":"Vivo Opportunity Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":30106,"kind":"organization","name":"Vivo Opportunity, LLC","position":7,"cik":"0001728970","reported_name":"Vivo Opportunity, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-02-09T20:37:46.000Z","date":"2021-02-09","kind":"purchase","acquired":true,"shares":175733,"price":20,"value":3514660.0,"ownership":{"direct":false,"nature":"By Vivo Capital Fund VIII, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"The securities reported herein are held of record by Vivo Capital Fund VIII, L.P. Vivo Capital VIII, LLC is the general partner of Vivo Capital Fund VIII, L.P. Edgar Engleman is one of three voting members of Vivo Capital VIII, LLC."}],"balance_after":1997216,"source":{"system":"sec-edgar","filing":"0001209191-21-008758","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1728970/000120919121008758/doc4.xml","form_type":"4"}},{"id":2872075,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":92274,"kind":"organization","name":"Vivo Capital VIII, LLC","position":1,"cik":"0001618789","reported_name":"Vivo Capital VIII, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":92275,"kind":"organization","name":"Vivo Capital Fund VIII, L.P.","position":2,"cik":"0001618788","reported_name":"Vivo Capital Fund VIII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":92276,"kind":"organization","name":"Vivo Capital Surplus Fund VIII, L.P.","position":3,"cik":"0001628048","reported_name":"Vivo Capital Surplus Fund VIII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":107996,"kind":"organization","name":"Vivo Panda Fund, L.P.","position":4,"cik":"0001675490","reported_name":"Vivo Panda Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":107995,"kind":"organization","name":"Vivo Panda, LLC","position":5,"cik":"0001843847","reported_name":"Vivo Panda, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":130985,"kind":"organization","name":"Vivo Opportunity Fund, L.P.","position":6,"cik":"0001726403","reported_name":"Vivo Opportunity Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":30106,"kind":"organization","name":"Vivo Opportunity, LLC","position":7,"cik":"0001728970","reported_name":"Vivo Opportunity, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-02-09T20:37:46.000Z","date":"2021-02-09","kind":"sale","acquired":false,"shares":144,"price":20,"value":2880.0,"ownership":{"direct":false,"nature":"By Vivo Capital Fund VIII, L.P."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F8","text":"Upon closing of the Issuer's IPO, Vivo Capital Fund VIII, L.P. exercised a warrant to purchase 40,953 shares of the Issuer's Common Stock at an exercise price per share of $0.07. Vivo Capital Fund VIII, L.P. paid the exercise price on a cashless basis, resulting in the Issuer withholding 144 share subject to the warrant in order to pay the exercise price and issuing to Vivo Capital Fund VIII, L.P. the remaining 40,809 shares of Common Stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"The securities reported herein are held of record by Vivo Capital Fund VIII, L.P. Vivo Capital VIII, LLC is the general partner of Vivo Capital Fund VIII, L.P. Edgar Engleman is one of three voting members of Vivo Capital VIII, LLC."}],"balance_after":1821483,"source":{"system":"sec-edgar","filing":"0001209191-21-008758","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1728970/000120919121008758/doc4.xml","form_type":"4"}},{"id":2872074,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":92274,"kind":"organization","name":"Vivo Capital VIII, LLC","position":1,"cik":"0001618789","reported_name":"Vivo Capital VIII, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":92275,"kind":"organization","name":"Vivo Capital Fund VIII, L.P.","position":2,"cik":"0001618788","reported_name":"Vivo Capital Fund VIII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":92276,"kind":"organization","name":"Vivo Capital Surplus Fund VIII, L.P.","position":3,"cik":"0001628048","reported_name":"Vivo Capital Surplus Fund VIII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":107996,"kind":"organization","name":"Vivo Panda Fund, L.P.","position":4,"cik":"0001675490","reported_name":"Vivo Panda Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":107995,"kind":"organization","name":"Vivo Panda, LLC","position":5,"cik":"0001843847","reported_name":"Vivo Panda, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":130985,"kind":"organization","name":"Vivo Opportunity Fund, L.P.","position":6,"cik":"0001726403","reported_name":"Vivo Opportunity Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":30106,"kind":"organization","name":"Vivo Opportunity, LLC","position":7,"cik":"0001728970","reported_name":"Vivo Opportunity, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-02-09T20:37:46.000Z","date":"2021-02-09","kind":"other","acquired":true,"shares":40953,"price":0.07,"value":2866.71,"ownership":{"direct":false,"nature":"By Vivo Capital Fund VIII, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"The securities reported herein are held of record by Vivo Capital Fund VIII, L.P. Vivo Capital VIII, LLC is the general partner of Vivo Capital Fund VIII, L.P. Edgar Engleman is one of three voting members of Vivo Capital VIII, LLC."}],"balance_after":1821627,"source":{"system":"sec-edgar","filing":"0001209191-21-008758","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1728970/000120919121008758/doc4.xml","form_type":"4"}},{"id":2872073,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":92274,"kind":"organization","name":"Vivo Capital VIII, LLC","position":1,"cik":"0001618789","reported_name":"Vivo Capital VIII, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":92275,"kind":"organization","name":"Vivo Capital Fund VIII, L.P.","position":2,"cik":"0001618788","reported_name":"Vivo Capital Fund VIII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":92276,"kind":"organization","name":"Vivo Capital Surplus Fund VIII, L.P.","position":3,"cik":"0001628048","reported_name":"Vivo Capital Surplus Fund VIII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":107996,"kind":"organization","name":"Vivo Panda Fund, L.P.","position":4,"cik":"0001675490","reported_name":"Vivo Panda Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":107995,"kind":"organization","name":"Vivo Panda, LLC","position":5,"cik":"0001843847","reported_name":"Vivo Panda, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":130985,"kind":"organization","name":"Vivo Opportunity Fund, L.P.","position":6,"cik":"0001726403","reported_name":"Vivo Opportunity Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":30106,"kind":"organization","name":"Vivo Opportunity, LLC","position":7,"cik":"0001728970","reported_name":"Vivo Opportunity, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-02-09T20:37:46.000Z","date":"2021-02-09","kind":"exercise","acquired":true,"shares":345568,"ownership":{"direct":false,"nature":"By Vivo Capital Fund VIII, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The Series C-2 Preferred Stock automatically converted into shares of Common Stock of the Issuer on a 1:1 basis immediately upon closing of the Issuer's IPO and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"The securities reported herein are held of record by Vivo Capital Fund VIII, L.P. Vivo Capital VIII, LLC is the general partner of Vivo Capital Fund VIII, L.P. Edgar Engleman is one of three voting members of Vivo Capital VIII, LLC."}],"balance_after":1780674,"source":{"system":"sec-edgar","filing":"0001209191-21-008758","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1728970/000120919121008758/doc4.xml","form_type":"4"}},{"id":2872072,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":92274,"kind":"organization","name":"Vivo Capital VIII, LLC","position":1,"cik":"0001618789","reported_name":"Vivo Capital VIII, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":92275,"kind":"organization","name":"Vivo Capital Fund VIII, L.P.","position":2,"cik":"0001618788","reported_name":"Vivo Capital Fund VIII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":92276,"kind":"organization","name":"Vivo Capital Surplus Fund VIII, L.P.","position":3,"cik":"0001628048","reported_name":"Vivo Capital Surplus Fund VIII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":107996,"kind":"organization","name":"Vivo Panda Fund, L.P.","position":4,"cik":"0001675490","reported_name":"Vivo Panda Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":107995,"kind":"organization","name":"Vivo Panda, LLC","position":5,"cik":"0001843847","reported_name":"Vivo Panda, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":130985,"kind":"organization","name":"Vivo Opportunity Fund, L.P.","position":6,"cik":"0001726403","reported_name":"Vivo Opportunity Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":30106,"kind":"organization","name":"Vivo Opportunity, LLC","position":7,"cik":"0001728970","reported_name":"Vivo Opportunity, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-02-09T20:37:46.000Z","date":"2021-02-09","kind":"exercise","acquired":true,"shares":317922,"ownership":{"direct":false,"nature":"By Vivo Capital Fund VIII, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The Series C-1 Preferred Stock automatically converted into shares of Common Stock of the Issuer on a 1:1 basis immediately upon closing of the Issuer's IPO and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"The securities reported herein are held of record by Vivo Capital Fund VIII, L.P. Vivo Capital VIII, LLC is the general partner of Vivo Capital Fund VIII, L.P. Edgar Engleman is one of three voting members of Vivo Capital VIII, LLC."}],"balance_after":1435106,"source":{"system":"sec-edgar","filing":"0001209191-21-008758","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1728970/000120919121008758/doc4.xml","form_type":"4"}},{"id":2872071,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":92274,"kind":"organization","name":"Vivo Capital VIII, LLC","position":1,"cik":"0001618789","reported_name":"Vivo Capital VIII, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":92275,"kind":"organization","name":"Vivo Capital Fund VIII, L.P.","position":2,"cik":"0001618788","reported_name":"Vivo Capital Fund VIII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":92276,"kind":"organization","name":"Vivo Capital Surplus Fund VIII, L.P.","position":3,"cik":"0001628048","reported_name":"Vivo Capital Surplus Fund VIII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":107996,"kind":"organization","name":"Vivo Panda Fund, L.P.","position":4,"cik":"0001675490","reported_name":"Vivo Panda Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":107995,"kind":"organization","name":"Vivo Panda, LLC","position":5,"cik":"0001843847","reported_name":"Vivo Panda, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":130985,"kind":"organization","name":"Vivo Opportunity Fund, L.P.","position":6,"cik":"0001726403","reported_name":"Vivo Opportunity Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":30106,"kind":"organization","name":"Vivo Opportunity, LLC","position":7,"cik":"0001728970","reported_name":"Vivo Opportunity, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-02-09T20:37:46.000Z","date":"2021-02-09","kind":"exercise","acquired":true,"shares":1092080,"ownership":{"direct":false,"nature":"By Vivo Capital Fund VIII, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The Series B Preferred Stock automatically converted into shares of Common Stock of the Issuer on a 1:1 basis immediately upon closing of the Issuer's IPO and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"The securities reported herein are held of record by Vivo Capital Fund VIII, L.P. Vivo Capital VIII, LLC is the general partner of Vivo Capital Fund VIII, L.P. Edgar Engleman is one of three voting members of Vivo Capital VIII, LLC."}],"balance_after":1117184,"source":{"system":"sec-edgar","filing":"0001209191-21-008758","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1728970/000120919121008758/doc4.xml","form_type":"4"}},{"id":2872070,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":92274,"kind":"organization","name":"Vivo Capital VIII, LLC","position":1,"cik":"0001618789","reported_name":"Vivo Capital VIII, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":92275,"kind":"organization","name":"Vivo Capital Fund VIII, L.P.","position":2,"cik":"0001618788","reported_name":"Vivo Capital Fund VIII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":92276,"kind":"organization","name":"Vivo Capital Surplus Fund VIII, L.P.","position":3,"cik":"0001628048","reported_name":"Vivo Capital Surplus Fund VIII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":107996,"kind":"organization","name":"Vivo Panda Fund, L.P.","position":4,"cik":"0001675490","reported_name":"Vivo Panda Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":107995,"kind":"organization","name":"Vivo Panda, LLC","position":5,"cik":"0001843847","reported_name":"Vivo Panda, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":130985,"kind":"organization","name":"Vivo Opportunity Fund, L.P.","position":6,"cik":"0001726403","reported_name":"Vivo Opportunity Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":30106,"kind":"organization","name":"Vivo Opportunity, LLC","position":7,"cik":"0001728970","reported_name":"Vivo Opportunity, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-02-09T20:37:46.000Z","date":"2021-02-09","kind":"sale","acquired":false,"shares":62,"price":20,"value":1240.0,"ownership":{"direct":false,"nature":"By Vivo PANDA Fund, L.P."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Upon closing of the Issuer's IPO, Vivo LP exercised a warrant to purchase 17,711 shares of the Issuer's Common Stock at an exercise price per share of $0.07. Vivo LP paid the exercise price on a cashless basis, resulting in the Issuer withholding 62 share subject to the warrant in order to pay the exercise price and issuing to Vivo LP the remaining 17,649 shares of Common Stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities reported herein are held of record by Vivo PANDA Fund, L.P. (\"Vivo LP\"). Vivo Panda, LLC (\"Vivo LLC\") is the sole general partner of Vivo LP. Mahendra G. Shah, Ph.D. is one of four voting members of Vivo LLC."}],"balance_after":1448286,"source":{"system":"sec-edgar","filing":"0001209191-21-008758","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1728970/000120919121008758/doc4.xml","form_type":"4"}},{"id":2872069,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":92274,"kind":"organization","name":"Vivo Capital VIII, LLC","position":1,"cik":"0001618789","reported_name":"Vivo Capital VIII, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":92275,"kind":"organization","name":"Vivo Capital Fund VIII, L.P.","position":2,"cik":"0001618788","reported_name":"Vivo Capital Fund VIII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":92276,"kind":"organization","name":"Vivo Capital Surplus Fund VIII, L.P.","position":3,"cik":"0001628048","reported_name":"Vivo Capital Surplus Fund VIII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":107996,"kind":"organization","name":"Vivo Panda Fund, L.P.","position":4,"cik":"0001675490","reported_name":"Vivo Panda Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":107995,"kind":"organization","name":"Vivo Panda, LLC","position":5,"cik":"0001843847","reported_name":"Vivo Panda, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":130985,"kind":"organization","name":"Vivo Opportunity Fund, L.P.","position":6,"cik":"0001726403","reported_name":"Vivo Opportunity Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":30106,"kind":"organization","name":"Vivo Opportunity, LLC","position":7,"cik":"0001728970","reported_name":"Vivo Opportunity, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-02-09T20:37:46.000Z","date":"2021-02-09","kind":"other","acquired":true,"shares":17711,"price":0.07,"value":1239.77,"ownership":{"direct":false,"nature":"By Vivo PANDA Fund, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities reported herein are held of record by Vivo PANDA Fund, L.P. (\"Vivo LP\"). Vivo Panda, LLC (\"Vivo LLC\") is the sole general partner of Vivo LP. Mahendra G. Shah, Ph.D. is one of four voting members of Vivo LLC."}],"balance_after":1448348,"source":{"system":"sec-edgar","filing":"0001209191-21-008758","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1728970/000120919121008758/doc4.xml","form_type":"4"}},{"id":2872068,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":92274,"kind":"organization","name":"Vivo Capital VIII, LLC","position":1,"cik":"0001618789","reported_name":"Vivo Capital VIII, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":92275,"kind":"organization","name":"Vivo Capital Fund VIII, L.P.","position":2,"cik":"0001618788","reported_name":"Vivo Capital Fund VIII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":92276,"kind":"organization","name":"Vivo Capital Surplus Fund VIII, L.P.","position":3,"cik":"0001628048","reported_name":"Vivo Capital Surplus Fund VIII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":107996,"kind":"organization","name":"Vivo Panda Fund, L.P.","position":4,"cik":"0001675490","reported_name":"Vivo Panda Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":107995,"kind":"organization","name":"Vivo Panda, LLC","position":5,"cik":"0001843847","reported_name":"Vivo Panda, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":130985,"kind":"organization","name":"Vivo Opportunity Fund, L.P.","position":6,"cik":"0001726403","reported_name":"Vivo Opportunity Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":30106,"kind":"organization","name":"Vivo Opportunity, LLC","position":7,"cik":"0001728970","reported_name":"Vivo Opportunity, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-02-09T20:37:46.000Z","date":"2021-02-09","kind":"exercise","acquired":true,"shares":472296,"ownership":{"direct":false,"nature":"By Vivo PANDA Fund, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The Series B Preferred Stock automatically converted into shares of Common Stock of the Issuer on a 1:1 basis immediately upon closing of the Issuer's IPO and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities reported herein are held of record by Vivo PANDA Fund, L.P. (\"Vivo LP\"). Vivo Panda, LLC (\"Vivo LLC\") is the sole general partner of Vivo LP. Mahendra G. Shah, Ph.D. is one of four voting members of Vivo LLC."}],"balance_after":1430637,"source":{"system":"sec-edgar","filing":"0001209191-21-008758","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1728970/000120919121008758/doc4.xml","form_type":"4"}},{"id":2872067,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":92274,"kind":"organization","name":"Vivo Capital VIII, LLC","position":1,"cik":"0001618789","reported_name":"Vivo Capital VIII, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":92275,"kind":"organization","name":"Vivo Capital Fund VIII, L.P.","position":2,"cik":"0001618788","reported_name":"Vivo Capital Fund VIII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":92276,"kind":"organization","name":"Vivo Capital Surplus Fund VIII, L.P.","position":3,"cik":"0001628048","reported_name":"Vivo Capital Surplus Fund VIII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":107996,"kind":"organization","name":"Vivo Panda Fund, L.P.","position":4,"cik":"0001675490","reported_name":"Vivo Panda Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":107995,"kind":"organization","name":"Vivo Panda, LLC","position":5,"cik":"0001843847","reported_name":"Vivo Panda, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":130985,"kind":"organization","name":"Vivo Opportunity Fund, L.P.","position":6,"cik":"0001726403","reported_name":"Vivo Opportunity Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":30106,"kind":"organization","name":"Vivo Opportunity, LLC","position":7,"cik":"0001728970","reported_name":"Vivo Opportunity, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-02-09T20:37:46.000Z","date":"2021-02-09","kind":"exercise","acquired":true,"shares":944056,"ownership":{"direct":false,"nature":"By Vivo PANDA Fund, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Series A-1 Preferred Stock automatically converted into shares of Common Stock of the Issuer on a 1:1 basis immediately upon closing of\nthe Issuer's initial public offering (the \"IPO\") and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities reported herein are held of record by Vivo PANDA Fund, L.P. (\"Vivo LP\"). Vivo Panda, LLC (\"Vivo LLC\") is the sole general partner of Vivo LP. Mahendra G. Shah, Ph.D. is one of four voting members of Vivo LLC."}],"balance_after":958341,"source":{"system":"sec-edgar","filing":"0001209191-21-008758","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1728970/000120919121008758/doc4.xml","form_type":"4"}}]}